Strategies for immune regulation in iPS cell-based cardiac regenerative medicine

Strategies for immune regulation in iPS cell-based cardiac regenerative medicine

Abstract Cardiac regenerative therapy is expected to be a promising therapeutic option for the treatment of severe cardiovascular diseases. Artificial tissues or organoids made from cardiovascular cell lineages differentiated from human induced pluripotent stem cells (iPSCs) are expected to regenera...

Full description

Bibliographic Details
Main Authors: Kozue Murata, Masaya Ikegawa, Kenji Minatoya, Hidetoshi Masumoto
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Inflammation and Regeneration
Subjects:
Induced pluripotent stem cells
Transplantation
Immune regulation
Cardiac regeneration
Online Access:http://link.springer.com/article/10.1186/s41232-020-00145-4

Internet

http://link.springer.com/article/10.1186/s41232-020-00145-4

Similar Items